MYD88 and diabetes mellitus: T1D participants with microvascular complications presented lower MYD88 mRNA expression when compared to T1D participants without microvascular complications (P = 0.0008 after adjustment for sex, age, HbA1C, diabetes duration, and use of ACEI, ARB, and statin) (Figure 2(b)).